| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-8703(96)90278-1 |
| P698 | PubMed publication ID | 8721646 |
| P2093 | author name string | Lowe GD | |
| Lip GY | |||
| Dunn FG | |||
| Rumley A | |||
| P2860 | cites work | Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment | Q36820491 |
| Thromboembolic complications of atrial fibrillation and their prevention: a review | Q37849573 | ||
| Thromboembolic complications in atrial fibrillation | Q38140438 | ||
| Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature | Q40904739 | ||
| Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. | Q41013214 | ||
| Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease | Q41072972 | ||
| Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography | Q43769453 | ||
| Spontaneous echo contrast in the left atrium during paroxysmal atrial fibrillation | Q44200497 | ||
| Embolic complications in paroxysmal atrial fibrillation | Q44202107 | ||
| Risk factors for systemic embolism in patients with paroxysmal atrial fibrillation | Q44963832 | ||
| Embolism in Sinoatrial Disease | Q67271400 | ||
| Systemic Embolism in Chronic Sinoatrial Disorder | Q67455557 | ||
| Left atrial spontaneous echo contrast: A clinical and echocardiographic analysis | Q67921185 | ||
| Measurement of crosslinked fibrin derivatives in patients undergoing abdominal surgery: use in the diagnosis of postoperative venous thrombosis | Q68192893 | ||
| Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortality | Q68444637 | ||
| Increased intracardiovascular clotting in patients with chronic atrial fibrillation | Q68860554 | ||
| Antithrombotic therapy in atrial fibrillation | Q69484101 | ||
| Significance of atrial fibrillation as a precursor of embolism | Q69623612 | ||
| Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation | Q69653833 | ||
| Cerebral computed tomography in paroxysmal atrial fibrillation | Q69732972 | ||
| Atrial fibrillation revisited | Q70294408 | ||
| Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation | Q70543019 | ||
| Clinical features of paroxysmal atrial fibrillation an observation of 94 patients | Q70769098 | ||
| Fibrin D-dimer: a useful clinical marker of thrombogenesis? | Q71572283 | ||
| Coronary heart disease and atrial fibrillation: the Framingham Study | Q71782665 | ||
| Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk | Q72382298 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atrial fibrillation | Q815819 |
| P304 | page(s) | 724-730 | |
| P577 | publication date | 1996-04-01 | |
| P1433 | published in | American Heart Journal | Q2227156 |
| P1476 | title | Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. | |
| P478 | volume | 131 |
| Q22306351 | ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation |
| Q35605552 | Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression |
| Q30234626 | Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes |
| Q47754048 | Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations? |
| Q73614954 | D-dimer determination as a screening tool to exclude atrial thrombi in atrial fibrillation |
| Q26800991 | Diagnosing Paroxysmal Atrial Fibrillation: Are Biomarkers the Solution to This Elusive Arrhythmia? |
| Q73396109 | Does paroxysmal atrial fibrillation confer a paroxysmal thromboembolic risk? |
| Q73065063 | Effect of batroxobin on spontaneous echo contrast and hemorheology in left atrial appendage in atrial fibrillation assessed by transesophageal echocardiograpy |
| Q35158979 | Fibrinolytic function and atrial fibrillation |
| Q36843189 | Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation |
| Q74267714 | Hemostatic markers in heart disease |
| Q57073286 | Hemostatic state and atrial fibrillation (The Framingham Offspring Study) |
| Q41343151 | Hypercoagulability and haemodynamic abnormalities in atrial fibrillation |
| Q38215163 | Hypercoagulability, D-dimer and atrial fibrillation: an overview of biological and clinical evidence |
| Q77643948 | Hypofibrinolysis in atrial fibrillation |
| Q36518566 | Impact of CHADS(2) Score on Neurological Severity and Long-Term Outcome in Atrial Fibrillation-Related Ischemic Stroke |
| Q36253510 | Inflammation and hemostasis in atrial fibrillation and coronary heart disease: The REasons for Geographic And Racial Differences in Stroke study |
| Q35818192 | Non-valvular atrial fibrillation and stroke: implications for nursing practice and therapeutics |
| Q28200609 | Optimising stroke prevention in non-valvular atrial fibrillation |
| Q73251328 | Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study) |
| Q75232834 | Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia |
| Q34314049 | Peripheral vascular disease and hypertension: a forgotten association? |
| Q37123391 | Pharmacotherapy of atrial fibrillation: an old option with new possibilities |
| Q30361899 | Plasma fibrin D-dimer and the risk of left atrial thrombus: A systematic review and meta-analysis |
| Q35582996 | Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation |
| Q39209674 | Predictive Role of Coagulation, Fibrinolytic, and Endothelial Markers in Patients with Atrial Fibrillation, Stroke, and Thromboembolism: A Meta-Analysis, Meta-Regression, and Systematic Review. |
| Q48565298 | Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. |
| Q43177431 | Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban |
| Q35285063 | Serum potassium levels inversely correlate with D-dimer in patients with acute-onset atrial fibrillation |
| Q37810505 | Stroke prevention treatment of patients with atrial fibrillation: old and new. |
| Q82794205 | The relationship between D-dimer level and the development of atrial fibrillation in patients with systolic heart failure |
| Q92107108 | Useful indices of thrombogenesis in the exclusion of intra-cardiac thrombus |
| Q50532806 | [Improvement in fibrinolytic function following anticoagulant treatment in chronic rheumatic atrial fibrillation] |
Search more.